{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-NSNWJQ2C/bac7c697-7137-4d2c-9a9c-d8b966eb1da7/PDF","dcterms:extent":"284 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-NSNWJQ2C/6734a992-bec0-40aa-8c24-bf65f8ccf008/TEXT","dcterms:extent":"57 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-NSNWJQ2C","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2024","dc:creator":["Battelino, Saba","Eržen, Nika","Golli, Tanja","Grosek, Štefan","Korpar, Bojan","Markelj, Špela","Mramor, Minca","Nosan, Gregor","Petrovec, Miroslav","Stropnik, Staša"],"dc:contributor":"Nosan, Gregor","dc:format":[{"@xml:lang":"sl","#text":"številka:5/6"},{"@xml:lang":"sl","#text":"letnik:93"},{"@xml:lang":"sl","#text":"str. 187-197"}],"dc:identifier":["DOI:10.6016/ZdravVestn.3481","ISSN:1318-0347","COBISSID:195862275","URN:URN:NBN:SI:doc-NSNWJQ2C"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"človeški citomegalovirus"},{"@xml:lang":"sl","#text":"novorojenčki"},{"@xml:lang":"sl","#text":"obravnava"},{"@xml:lang":"sl","#text":"presejanje novorojenčkov"},{"@xml:lang":"sl","#text":"prirojene okužbe s citomegalovirusom"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Prirojena okužba s citomegalovirusom| usmerjeno presejanje novorojenčkov in protokol obravnave| Congenital cytomegalovirus infection| targeted newborn screening and follow-up protocol|"},"dc:description":[{"@xml:lang":"sl","#text":"Congenital cytomegalovirus infection (cCMV) is the most common congenital infection in developed countries and the most common infectious cause of sensorineural hearing loss and neurodevelopmental disorders. Only a small proportion of children with cCMV have a symptomatic disease at birth, while a larger proportion of them are clinically asymptomatic. Nevertheless, all children with cCMV may develop long-term neurodevelopmental disorders, especially sensorineural hearing loss. According to the European epidemiological data and the Slovenian incidence of cCMV, which is 0.14%, a not insignificant low number of children with cCMV are born in Slovenia. Currently, we detect only a small proportion of newborns with pCMV, mainly those with symptomatic disease at birth. Until universal screening of pregnant women and newborns is available for cCMV, we should consistently perform a targeted screening to prevent hearing loss and improve the long-term neurodevelopmental outcome in children with cCMV. In this review, we present the recommendations for targeted newborn screening and a follow-up protocol for children with cCMV"},{"@xml:lang":"sl","#text":"Prirojena okužba s citomegalovirusom (pCMV) je v razvitih državah najpogostejša prirojena okužba ter najpogostejši vzrok za senzorinevralno okvaro sluha in razvojnonevrološke motnje. Le manjši delež otrok s pCMV ima ob rojstvu izražene znake bolezni, medtem ko je pri večjem deležu otrok s pCMV ob rojstvu okužba klinično nema. Vendar ti otroci lahko kljub temu dolgoročno razvijejo razvojnonevrološko motnjo. Zlasti so ogroženi za nastanek okvare sluha. Glede na evropske epidemiološke podatke in ocenjeno incidenco pCMV v Sloveniji, ki znaša 0,14 %, se pri nas rodi nezanemarljivo število otrok s pCMV. Danes odkrijemo le manjši delež novorojenčkov s pCMV, večinoma le tiste, ki imajo ob rojstvu tudi izražene znake bolezni. Dokler za to bolezen ni univerzalnega presejanja nosečnic in novorojenčkov na pCMV, je smiselno dosledno izvajati usmerjeno presejanje novorojenčkov ter z ustrezno obravnavo izboljšati dolgoročni razvojnonevrološki izid pri otrocih. V prispevku predstavljamo izhodišča za usmerjeno presejanje novorojenčkov na pCMV ter protokol obravnave otrok s pCMV"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-NSNWJQ2C","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-NSNWJQ2C"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-NSNWJQ2C/bac7c697-7137-4d2c-9a9c-d8b966eb1da7/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-NSNWJQ2C/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-NSNWJQ2C"}}}}